National Health Surveillance Agency (Anvisa) published a technical note this Tuesday (29). After the admission of the new product protocol, the team will analyze documentation within 20 days.
/i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2020/m/i/THrPOLT3yebC7BxZaXew/2020-09-25t020728z-2132933524-rc2e5j92ltke-rtrmadp-3-health-coronavirus-usa.jpg)
The National Health Surveillance Agency (Anvisa) published a technical note on Tuesday (29) that reduces the initial documentation and simplifies the registration for vaccines of Covid-19. The name of the procedure is “continuous submission”.